DaVita Overview
- Year Founded
-
1979
- Status
-
Public
- Employees
-
70,000
- Stock Symbol
-
DVA
- Investments
-
60
- Share Price
-
$163.74
- (As of Monday Closing)
DaVita General Information
Description
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.
Contact Information
Website
www.davita.comCorporate Office
- 2000 16th Street
- Denver, CO 80202
- United States
Corporate Office
- 2000 16th Street
- Denver, CO 80202
- United States
DaVita Timeline
DaVita Stock Performance
As of 02-Dec-2024, DaVita’s stock price is $163.74. Its current market cap is $13.4B with 82M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $163.74 | $166.17 | $103.40 - $169.51 | $13.4B | 82M | 810K | $9.53 |
DaVita Financials Summary
As of 30-Sep-2024, DaVita has a trailing 12-month revenue of $12.7B.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 26,784,242 | 21,863,237 | 19,862,836 | 24,164,940 |
| Revenue | 12,666,614 | 12,140,147 | 11,609,894 | 11,618,797 |
| EBITDA | 2,578,700 | 2,348,052 | 2,055,899 | 2,484,363 |
| Net Income | 827,678 | 691,535 | 560,400 | 978,450 |
| Total Assets | 17,503,737 | 16,893,578 | 16,928,252 | 17,121,488 |
| Total Debt | 12,198,261 | 11,116,421 | 11,822,490 | 11,975,250 |
DaVita Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DaVita Comparisons
Industry
Financing
Details
DaVita Competitors (5)
One of DaVita’s 5 competitors is Select Medical Holdings, a Formerly PE-Backed company based in Mechanicsburg, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Select Medical Holdings | Formerly PE-Backed | Mechanicsburg, PA | ||||
| Encompass Health | Formerly VC-backed | Birmingham, AL | ||||
| Fresenius Medical Care | Corporation | Bad Homburg v.d. Höhe, Germany | ||||
| U.S. Renal Care | Private Equity-Backed | Plano, TX | ||||
| Fresenius | Corporation | Bad Homburg, Germany |
DaVita Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
DaVita Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DaVita Investments & Acquisitions (60)
DaVita’s most recent deal was a Later Stage VC with Egenesis for . The deal was made on 04-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Egenesis | 04-Sep-2024 | Later Stage VC | Biotechnology | ||
| Fresenius Medical Care (Dialysis Clinic Businesses in Brazil, Colombia, Chile, Ecuado) | 05-Mar-2024 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Kidney Health Technology (Davita / Medtronic) | 26-May-2022 | Joint Venture | Therapeutic Devices | ||
| MedSleuth | 31-Dec-2021 | Merger/Acquisition | Enterprise Systems (Healthcare) | ||
| Renal Services | 04-Feb-2021 | Merger/Acquisition | Clinics/Outpatient Services |
DaVita Subsidiaries (397)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| DaVita Venture Group | Corporate Venture Capital | Denver, CO | 2020 |
| Bemity Dialysis | Clinics/Outpatient Services | Denver, CO | |
| Madigan Dialysis | Clinics/Outpatient Services | Brentwood, TN | |
| Lifeline Vascular Center-Albany | Clinics/Outpatient Services | Denver, CO | |
| Lifeline Vascular Center of South Orlando | Clinics/Outpatient Services | Denver, CO |
DaVita ESG
Risk Overview
Risk Rating
Updated June, 04, 2024
21.78 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,035
Rank
Percentile
Healthcare
Industry
of 588
Rank
Percentile
Medical Services
Subindustry
of 102
Rank
Percentile
DaVita Exits (9)
DaVita’s most recent exit was on 01-Mar-2016 from The Everett Clinic. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| The Everett Clinic | 01-Mar-2016 | Completed |
|
||
| DaVita Care (India) | 23-Jan-2014 | Completed |
|
||
| CVRx | 30-Oct-2013 | Completed |
|
||
| Lifeline Vascular Care | 31-Jul-2013 | Completed |
|
||
| DaVita Medical Group | 01-Nov-2012 | Merger/Acquisition | Completed |
DaVita FAQs
-
When was DaVita founded?
DaVita was founded in 1979.
-
Where is DaVita headquartered?
DaVita is headquartered in Denver, CO.
-
What is the size of DaVita?
DaVita has 70,000 total employees.
-
What industry is DaVita in?
DaVita’s primary industry is Hospitals/Inpatient Services.
-
Is DaVita a private or public company?
DaVita is a Public company.
-
What is DaVita’s stock symbol?
The ticker symbol for DaVita is DVA.
-
What is the current stock price of DaVita?
As of 02-Dec-2024 the stock price of DaVita is $163.74.
-
What is the current market cap of DaVita?
The current market capitalization of DaVita is $13.4B.
-
What is DaVita’s current revenue?
The trailing twelve month revenue for DaVita is $12.7B.
-
Who are DaVita’s competitors?
Select Medical Holdings, Encompass Health, Fresenius Medical Care, U.S. Renal Care, and Fresenius are competitors of DaVita.
-
What is DaVita’s annual earnings per share (EPS)?
DaVita’s EPS for 12 months was $9.53.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
